Climb Bio, Inc. CLYM Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Climb Bio, Inc. (CLYM) reported accretion (amortization) of discounts and premiums, investments of $305K in Q1 2026.
- How has Climb Bio, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Climb Bio, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 54.4% year-over-year, from $669K to $305K.
- What is the long-term trend for Climb Bio, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 4 years (2021 to 2025), Climb Bio, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 57.5% compound annual growth rate (CAGR), from -$370K to $2.27M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- Reflects the non-cash adjustment to the carrying value of investment securities due to the amortization of premiums or accretion of discounts over the life of the instrument. This adjustment reconciles the difference between the purchase price and the face value of debt securities held by the company.